Delta Investment Management LLC Increases Stock Position in Colgate-Palmolive Company $CL

Delta Investment Management LLC grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 3.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,226 shares of the company’s stock after acquiring an additional 137 shares during the quarter. Delta Investment Management LLC’s holdings in Colgate-Palmolive were worth $396,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CL. Price T Rowe Associates Inc. MD boosted its holdings in shares of Colgate-Palmolive by 18.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after acquiring an additional 5,269,140 shares during the last quarter. Nuveen LLC bought a new position in shares of Colgate-Palmolive in the 1st quarter worth approximately $217,593,000. Goldman Sachs Group Inc. lifted its stake in shares of Colgate-Palmolive by 34.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after purchasing an additional 2,045,191 shares during the period. Deutsche Bank AG lifted its stake in shares of Colgate-Palmolive by 35.6% in the 4th quarter. Deutsche Bank AG now owns 6,922,994 shares of the company’s stock worth $629,369,000 after purchasing an additional 1,816,865 shares during the period. Finally, Diamond Hill Capital Management Inc. lifted its stake in shares of Colgate-Palmolive by 45.0% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock worth $521,250,000 after purchasing an additional 1,727,105 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 7th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating on the stock in a research note on Monday, August 4th. JPMorgan Chase & Co. decreased their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Barclays raised their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 15th. Finally, Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.92.

Colgate-Palmolive Trading Up 0.3%

Shares of CL opened at $84.37 on Thursday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1 year low of $82.40 and a 1 year high of $109.30. The company has a 50 day simple moving average of $87.32 and a two-hundred day simple moving average of $89.86. The firm has a market cap of $68.19 billion, a P/E ratio of 23.70, a price-to-earnings-growth ratio of 4.38 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same period last year, the firm posted $0.91 EPS. The company’s revenue was up 1.0% on a year-over-year basis. On average, equities analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive’s payout ratio is currently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.